Searchable abstracts of presentations at key conferences in endocrinology

ea0037oc8.5 | Endocrine tumours | ECE2015

Oestrogen receptor α promotes prostate cancer progression through dual actions in both epithelia and stroma

Lawrence Mitchell , Pidsley Ruth , Ellem Stuart , Furic Luc , Nair Shalima , French Hugh , Stratham Aaron , Larsson Ola , Frydenberg Mark , Pedersen John , Buchanan Grant , Taylor Renea , Clark Susan , Risbridger Gail

In human prostate, Oestrogen receptor α (ERα) expression in the epithelium increases with tumour Grade and promotes proliferation involving classical genomic and rapid non-genomic signalling, as well as transcription regulation of non-coding RNA. Similarly, in the tumour stroma there is up-regulation of ERα, corresponding with declining AR, resulting in a higher ratio of ERα:AR with increasing Grade. Additionally, in prostate cancer-associated fibroblasts (...

ea0035oc10.4 | Endocrine Tumours | ECE2014

Mast cell interactions at tumour interface drive progression in human prostate cancer

Risbridger Gail , Ellem Stuart , Taylor Renea , Frydenberg Mark , Pook David , Pedersen John , Bioresource APC , Hashimoto Kohei , Seach Natalie , Clark Ashlee , Hutmacher Dietmar , Pardo Elena

Introduction: Prostate cancer is hormone dependent and regulated by a balance of androgens as well as estrogens. Regulatory control is also exerted by the tumor microenvironment including cancer-associated fibroblasts (CAFs), and immune cells. Although patient derived xenografts (PDX) commonly used to study the functional effects of CAFs, the method is not quantitative, is lengthy, technically challenging and the xenografts are placed in immune suppressed hosts excluding immun...